Covid-19: Trials to begin from Monday for evaluation of new vaccine: US govt official

A clinical trial will be conducted on Monday evaluating new vaccine designed to protect against the coronavirus, according to a government official of United States. The first participant in the trial will receive the experimental vaccine on Monday, the official said, speaking on the condition of anonymity.

According to the official, “The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle.” Public health officials said that “it will take a year to 18 months to fully validate any potential vaccine.”

Testing will begin with a 45 year young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. There’s no chance that participants could get infected from the shots, because they don’t contain the virus itself. The aim is purely to check that whether the vaccines show worrisome side effects or not, setting the stage for larger tests.

Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. Importantly, they’re pursuing different types of vaccines – shots developed from new technologies that not only are faster to produce than traditional inoculations but might prove more potent.

Some researchers even aim for temporary vaccines, such as shots that might guard people’s health a month or two at a time while longer-lasting protection is developed. For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia or in extreme cases, death also.

  • Related Posts

    • Health
    • February 10, 2024
    • 236 views
    Appointment of CEO packs a Punch in NeuroEqulibrium’s Global Goal

    New Delhi: The ambition of NeuroEquilibrium gets a shot in the arm with the appointment of industry vetran Samit Verma as its CEO (Chief Executive Officer). Its global aspiration will…

    Millets reigned Supreme in International Symposium on Gut Health

    New Delhi: Millets reign supreme as gut health assumes most important aspect of the latest preventive and curative healthcare approach. This fact was writ large on Symposium on ‘Gut Health…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt